David Braun, MD, on phase 2 trial of an individualized neoantigen therapy for RCC

Retrieved on: 2025-02-15 16:28:58

Tags for this article:

Click the tags to see associated articles and topics

David Braun, MD, on phase 2 trial of an individualized neoantigen therapy for RCC. View article details on hiswai:

Excerpt

Can we tell the immune system exactly where to go to attack the cancer in a very specific way? That's really the rationale and motivation for the ...

Article found on: www.urologytimes.com